
Bucking trends.
Backed by experience.
We’re developing therapies to reverse the debilitating consequences of damage and disease of the brain and spinal cord to restore independence and improve lives.
Leadership
-
Travis Stiles, PhD
CEO & Co-founder
-
David Weiner, MD
Executive Chairman
-
William Hoekstra, PhD
Drug Discovery & Development
-
Lynne Mayman, MS, PMP
Project Management
-
Sarah Busch, PhD
Non-Clinical Translation
-
Ryan McMillian, MBA
CFO & Financial Strategy
-
Shawn Gahr, MIA
COO & Co-founder
Scientific Advisory Board
-
Lawrence Goldstein, PhD
-
Jennifer Rauch, PhD
-
Kurt Brunden, PhD
-
James Whisstock, PhD
-
Rivka Kreitman, PhD
-
Miguel de los Rios, PhD
Spinal Cord Injury Advisory Council
-
Michael G. Fehlings, MD, PhD
-
Linda Jones, PT, Ph.D.
-
Bryn Martin, PhD
-
Robert Eastlack, MD
Board of Directors
-
Travis Stiles, PhD
Chairman of the Board
-
David Weiner, MD
Board Member
-
Mike Goguen
Board Member
-
Shawn Gahr
Board Member